174 related articles for article (PubMed ID: 17216542)
1. No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population.
Onen IH; Konac E; Eroglu M; Guneri C; Biri H; Ekmekci A
Mol Biol Rep; 2008 Mar; 35(1):17-22. PubMed ID: 17216542
[TBL] [Abstract][Full Text] [Related]
2. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
[TBL] [Abstract][Full Text] [Related]
4. Positive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancer.
Martinez-Fierro ML; Garza-Veloz I; Rojas-Martinez A; Ortiz-Lopez R; Castruita-de la Rosa C; Ortiz-Castro Y; Lazalde-Ramos BP; Cervantes-Villagrana AR; Castañeda-Lopez ME; Gomez-Guerra L; Delgado-Enciso I; Martinez-Torres AA
Cancer Biomark; 2013; 13(4):235-41. PubMed ID: 24240584
[TBL] [Abstract][Full Text] [Related]
5. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.
Sfar S; Hassen E; Saad H; Mosbah F; Chouchane L
Cytokine; 2006 Jul; 35(1-2):21-8. PubMed ID: 16908180
[TBL] [Abstract][Full Text] [Related]
6. The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population.
Onen IH; Ekmekci A; Eroglu M; Polat F; Biri H
DNA Cell Biol; 2007 Feb; 26(2):100-7. PubMed ID: 17328668
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of VEGF-460C/T associated with the risk and clinical characteristics of lung cancer in Chinese population.
Sun SF; Huang DB; Cao C; Deng ZC
Med Oncol; 2013 Mar; 30(1):410. PubMed ID: 23288726
[TBL] [Abstract][Full Text] [Related]
8. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M
Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608
[TBL] [Abstract][Full Text] [Related]
9. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
Fukuda H; Tsuchiya N; Narita S; Kumazawa T; Horikawa Y; Inoue T; Saito M; Yuasa T; Matsuura S; Satoh S; Ogawa O; Habuchi T
Oncol Rep; 2007 Nov; 18(5):1155-63. PubMed ID: 17914566
[TBL] [Abstract][Full Text] [Related]
10. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
11. Association of 5'UTR polymorphism of secretory phospholipase A2 group IIA (PLA2G2A) gene with prostate cancer metastasis.
Ozturk K; Onal MS; Efiloglu O; Nikerel E; Yildirim A; Telci D
Gene; 2020 Jun; 742():144589. PubMed ID: 32179174
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor and tumor necrosis factor genes polymorphisms in Turkish patients with sarcoidosis.
Seyhan EC; Cetinkaya E; Günlüoğlu Z; Altin S; Yüksel V; Işsever H
Tuberk Toraks; 2008; 56(1):5-14. PubMed ID: 18330749
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor gene +813CC polymorphism of foetus is associated with preterm labour but not with pre-eclampsia in Turkish pregnant women.
Atis A; Oruc O; Aydin Y; Cetincelik U; Goker N
Int J Immunogenet; 2012 Jun; 39(3):241-6. PubMed ID: 22257487
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a Chinese Han population.
Zhou Y; Li N; Zhuang W; Wu X
Mol Carcinog; 2011 Mar; 50(3):184-8. PubMed ID: 21344505
[TBL] [Abstract][Full Text] [Related]
15. The T -786C, G894T, and Intron 4 VNTR (4a/b) Polymorphisms of the Endothelial Nitric Oxide Synthase Gene in Prostate Cancer Cases.
Diler SB; Öden A
Genetika; 2016 Feb; 52(2):249-54. PubMed ID: 27215040
[TBL] [Abstract][Full Text] [Related]
16. Association of vascular endothelial growth factor -2578C/A gene polymorphism in Chinese patients with colon cancer.
Zhang L; Zhang G; Wang P; Gong J; Cao Y; Tang L
Genet Test Mol Biomarkers; 2011 Mar; 15(3):117-21. PubMed ID: 21091242
[TBL] [Abstract][Full Text] [Related]
17. Association of Autophagy Gene ATG16L1 Polymorphism with Human Prostate Cancer and Bladder Cancer in Turkish Population.
Budak Diler S; Aybuğa F
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2625-2630. PubMed ID: 30256070
[TBL] [Abstract][Full Text] [Related]
18. TSP1 and MMP9 genetic variants in sporadic prostate cancer.
Sfar S; Saad H; Mosbah F; Gabbouj S; Chouchane L
Cancer Genet Cytogenet; 2007 Jan; 172(1):38-44. PubMed ID: 17175378
[TBL] [Abstract][Full Text] [Related]
19. Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.
Chen J; Cui X; Zhou H; Qin C; Cao Q; Ju X; Li P; Cai H; Zhu J; Meng X; Wang M; Zhang Z; Shao P; Li J; Yin C
BMC Cancer; 2013 Jul; 13():356. PubMed ID: 23883402
[TBL] [Abstract][Full Text] [Related]
20. Association of six susceptibility Loci with prostate cancer in northern chinese men.
Zhang YR; Xu Y; Yang K; Liu M; Wei D; Zhang YG; Shi XH; Wang JY; Yang F; Wang X; Liang SY; Zhao CX; Wang F; Chen X; Sun L; Zhu XQ; Zhu L; Yang YG; Tang L; Jiao HY; Huo ZH; Yang Z
Asian Pac J Cancer Prev; 2012; 13(12):6273-6. PubMed ID: 23464444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
